Clinical Trial Update: An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI [Phase 2]

View source ↗

Summary

Phase 2 open-label trial evaluating inhalation profile via acoustic monitoring in COPD patients using the NEXThaler DPI; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• NEXThaler DPI

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: COPD | Phase 2 | Status: COMPLETED